Benzinga | Mar 30, 2021 06:35AM EDT

Akamai Launches COVID-19 Vaccine Management Solution Built On Salesforce Vaccine Cloud

Akamai Technologies, Inc. (NASDAQ:AKAM), a trusted solution for protecting and delivering digital experiences, today announced it has developed Akamai Vaccine Edge ("Vaccine Edge") for Salesforce Vaccine Cloud, to help government agencies, healthcare organizations, businesses, nonprofits and educational institutions scale their online distribution of COVID-19 vaccines. Complementing Salesforce's recently launched Vaccine Cloud, which provides a rapid and flexible approach for managing, delivering, and administering centralized vaccine programs, Vaccine Edge helps enhance the registration and signup process when websites are under duress due to high demand.